Namita Mahapatra Selected Research

enzaplatovir

1/2021

Drug repurposing for identification of potential inhibitors against SARS-CoV-2 spike receptor-binding domain: An in silico approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Namita Mahapatra Research Topics

Disease

2	Dengue (Dengue Fever) 01/2017 - 07/2016
1	COVID-19 01/2021
1	Neoplasms (Cancer) 01/2019
1	Leprosy (Hansen's Disease) 12/2018
1	Malaria 07/2009

Drug/Important Bio-Agent (IBA)

1	tideglusibIBA 01/2021
1	daclatasvirIBA 01/2021
1	dolutegravirIBA 01/2021
1	grazoprevirIBA 01/2021
1	SimeprevirIBA 01/2021
1	remdesivirIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	enzaplatovirIBA 01/2021
1	Chalcone (Benzalacetophenone)IBA 01/2021
1	presatovirIBA 01/2021
1	Ethanol (Ethyl Alcohol)IBA 01/2019
1	Dapsone FDA Link 12/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017
1	panduratin AIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	LigandsIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	VaccinesIBA 07/2016
1	Chloroquine (Aralen)FDA LinkGeneric 07/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 12/2018